Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Wednesday, October 14, 2026

Back to today

October 2026 Random Ramblings

October 2026 market commentary covers SOLS’s cancelled merger, a hypothetical Starbucks-Chipotle deal, Russell 2000 weakness and AI premiums for Oura and home builders.

SOLS $9.6BSBUX $113B
Yet Another Value Podcast 87 clicks

From X

@BlueDuckCap

BDC on X

This is obviously unsustainable. The larger the gap, the worse the crash. Semis are printing cash now - but for a buyer and seller relationship to be healthy over a long time, everyone, both sides, needs to make $. I think $AMZN can make $ because their flagship business sells compute capacity and their capex ramp has funded more capacity to sell. $META can work because their flagship biz benefits from internal AI and they may in fact have excess compute capacity to sell - which is a positive pivot. $GOOGL is less clear to me. Their flagship biz is soaking up internal compute because new entrants in search, gPT for one, have $750B in capex earmarked - not to sell compute but to improve their own frontier capabilities. At the same time, $GOOGL's external compute biz is going to do great - but in this theater they are also competing with AMZN/MSFT etc. So for $GOOGL there's no pivot opportunity akin to $META and there's 2x the capex need as the arms race accelerates for both internal and external needs.
@BrokenMoats

Broken Moats on X

$DHR move this week is odd. I know its trading off $TMO today but the bioprocessing is the bigger piece to DHR and those sales/guide were disappointing and you saw weak action from https://t.co/sj9MDhumCh today off their numbers and even $RGEN trading off. $165 - $190 in two days this week seems off. Maybe the initial flush was over done, but hard to argue this business deserves to trade back at 200 where it came into earnings after seeing the bioprocessing commentary. Seems like a fade at 190

Investor Letters

All letters

My 2028 numbers

ASML’s €11.7 billion quarter benefited from €3.3 billion in installed-base sales and operating leverage, while the MATCH Act threatens…

ASML $631B
Best Anchor Stocks 27 clicks

Lennar, Part One: The Story

Lennar grew from a Miami builder into one of America’s two largest homebuilders, controlling land largely through options and land banks…

LEN $18B
Latticework by MOI Global 15 clicks

Lennar, Part Two: The Deep Dive

Lennar’s second audio program examines the homebuilder’s business for professional investors and housing analysts.

LEN $18B
Latticework by MOI Global 13 clicks

ASML Q3 FY12/26 Earnings Review

ASML reported Q3 sales of €11.7 billion, up 55% year over year, and guided Q4 sales to €14.2 billion to €15.2 billion amid capacity…

ASML $631B
Cestrian Capital Research 10 clicks

Insider activity September 2026

Asian insider buying rose 19% to US$2.4 billion across 930 September transactions, led by Grab CEO Anthony Tan’s US$30 million purchase…

GRAB $12B
Asian Century Stocks 8 clicks
SRTA · long

Strata Critical Medical INC

Strata Critical Medical, SRTA, supplies organ-transport products tied to U.S. transplant growth.

SRTA $415M
Value Investors Club 3 clicks

Expert Call | Corning

Corning’s NVIDIA-backed 10x fiber expansion, enterprise connector demand and carrier capacity plans frame its optical communications…

GLW $115B
P Equity Research 38 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 54 of 245

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

90 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.